A new doctrine could soon take hold in part of the US war on drugs: psychedelic drugs for active-duty soldiers suffering from PTSD.
In two studies funded by the Department of Defense (DoD), 186 service personnel with PTSD will likely next year undergo multiple sessions of MDMA-assisted therapy.
The deputy under secretary of war for personnel and readiness, Sean O’Keefe, is following the research closely, a January letter shows, and a new group of DoD and Veterans Affairs (VA) department therapists are to begin training in psychedelic-assisted therapy next week ahead of soldier enrollment.
It is hoped guided sessions with the euphoria-inducing drug could, perhaps counterintuitively, help soldiers fight for their country for longer – and that once they leave the military they will not be crippled by traumatic stress.
The Pentagon has raised Israel’s counterintelligence threat level to its highest category, amid growing alarm that...
The Department of Defense moved this week to dramatically reduce the number of recognized religions, faiths...
June 6, 1944: The Day That Changed the War
Before sunrise on June 6, 1944, thousands of...
The House Armed Services Committee adopted a provision for the annual National Defense Authorization Act (NDAA)...
